Straightforward Access to 3,4‐Dihydro‐2 H ‐1,2,4‐benzothiadiazine 1,1‐dioxides and Quinazolines via Iron‐Catalyzed Aerobic Oxidative Condensation of Amines
- 10 May 2019
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 4 (18) , 5200-5205
Abstract
A novel and straightforward approach for constructing 3,4‐dihydro‐2 H ‐1,2,4‐benzothiadiazine 1,1‐dioxides from 2‐aminobenzenesulfonamide and benzylamines via oxidative condensation has been explored. Abundant and cheap iron salt as a catalyst and air as an oxidant were employed, which makes the process more practical and economical. This reaction protocol was further applied to synthesize diverse functionalized quinazolines through oxidative condensation of 2‐aminobenzylamines with benzylamines. Besides this, the use of amino acid such as phenylglycine as benzylamine surrogate has also been tested for the construction of 3,4‐dihydro‐2 H ‐1,2,4‐benzothiadiazine 1,1‐dioxide and quinazoline derivatives. The proposed mechanistic pathway has been validated by isolating the key intermediates.Keywords
Funding Information
- CSIR (02(0332)/18/EMR-II)
This publication has 55 references indexed in Scilit:
- 7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar PotencyJournal of Medicinal Chemistry, 2017
- Synthesis and Reactivity of 2‐Arylquinazoline Halidoruthenacycles in Arylation ReactionsChemCatChem, 2017
- Alpha-blockers for the Treatment of Benign Prostatic HyperplasiaUrologic Clinics of North America, 2016
- Anion directed structural diversity in zinc complexes with conformationally flexible quinazoline ligand: structural, spectral and theoretical studiesDalton Transactions, 2016
- Quinazoline derivatives as anticancer drugs: a patent review (2011 – present)Expert Opinion on Therapeutic Patents, 2015
- Linagliptin provides effective, well‐tolerated add‐on therapy to pre‐existing oral antidiabetic therapy over 1 year in Japanese patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2013
- Acetic Acid Derivatives of 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxide as a Novel Class of Potent Aldose Reductase InhibitorsJournal of Medicinal Chemistry, 2010
- Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking studyEuropean Journal of Medicinal Chemistry, 2010
- Molecular features of the prazosin molecule required for activation of Transport-PBioorganic & Medicinal Chemistry, 2008
- NEUROPHARMACOKINETICS OF A NEW α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC ACID (AMPA) MODULATOR, S18986 [(S)-2,3-DIHYDRO-[3,4]CYCLOPENTANO-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE], IN THE RATDrug Metabolism and Disposition, 2005